These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2400360)

  • 1. Hirsutism in a gynaecological context.
    McKenna KM; Pepperell RJ; Evans J
    Aust N Z J Obstet Gynaecol; 1990 May; 30(2):153-6. PubMed ID: 2400360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spironolactone in combination with an oral contraceptive: an alternative treatment for hirsutism.
    Chapman MG; Dowsett M; Dewhurst CJ; Jeffcoate SL
    Br J Obstet Gynaecol; 1985 Sep; 92(9):983-5. PubMed ID: 4041402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hirsutism].
    van Zuuren EJ; Pijl H
    Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2313-8. PubMed ID: 18064932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
    Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F
    Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients.
    Ciotta L; Cianci A; Marletta E; Pisana L; Aglianò A; Palumbo G
    Fertil Steril; 1994 Dec; 62(6):1129-35. PubMed ID: 7957975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of flutamide in the management of hirsutism.
    Marugo M; Bernasconi D; Meozzi M; Del Monte P; Zino V; Primarolo P; Badaracco B
    J Endocrinol Invest; 1994 Mar; 17(3):195-9. PubMed ID: 8051342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone as a single agent for long-term therapy of hirsute patients.
    Spritzer PM; Lisboa KO; Mattiello S; Lhullier F
    Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum prostate-specific antigen concentrations are not useful for monitoring the treatment of hirsutism with oral contraceptive pills.
    Escobar-Morreale HF; Avila S; Sancho J
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2488-92. PubMed ID: 10902798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.
    Timpatanapong P; Rojanasakul A
    J Dermatol; 1997 Apr; 24(4):223-9. PubMed ID: 9164062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
    Falsetti L; Galbignani E
    Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spironolactone for hirsutism in polycystic ovary syndrome.
    Christy NA; Franks AS; Cross LB
    Ann Pharmacother; 2005 Sep; 39(9):1517-21. PubMed ID: 16076921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone agonist (GnRH-A) in hirsutism.
    Falsetti L; Pasinetti E; Ceruti D
    Acta Eur Fertil; 1994; 25(5):303-6. PubMed ID: 7660719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex steroids, adiposity and smoking in the pathogenesis of idiopathic hirsutism and polycystic ovary syndrome.
    Byrne B; Cunningham S; Igoe D; Conroy R; McKenna TJ
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):370-4. PubMed ID: 1827700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flutamide: a rational approach to hirsutism.
    Vitale F; Ruggieri P
    Acta Eur Fertil; 1992; 23(1):33-5. PubMed ID: 1293898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
    Adams J; Polson DW; Franks S
    Br Med J (Clin Res Ed); 1986 Aug; 293(6543):355-9. PubMed ID: 3089520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
    Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
    Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of spironolactone on testosterone fractions and sex-hormone binding globulin binding capacity in hirsute women.
    Marcondes JA; Minanni SL; Luthold WW; Lerário AC; Nery M; Mendonça BB; Wajchenberg BL; Kirschner MA
    J Endocrinol Invest; 1995 Jun; 18(6):431-5. PubMed ID: 7594237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of 'obesity-associated gonadal dysfunction' in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis.
    Escobar-Morreale HF; Santacruz E; Luque-Ramírez M; Botella Carretero JI
    Hum Reprod Update; 2017 Jul; 23(4):390-408. PubMed ID: 28486593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hirsutism with spironolactone.
    Cumming DC; Yang JC; Rebar RW; Yen SS
    JAMA; 1982 Mar; 247(9):1295-8. PubMed ID: 7199587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.